(Q36022199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Zahra Kashi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

A R Mohammad Pour

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E Adibi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

Iranian Red Crescent medical journal

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

749-750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371879

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371879

Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371879

Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371879

Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study

23 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

[Bromocriptine for refractory rheumatoid arthritis]

1 reference

12 December 2020

Treatment of rheumatoid arthritis with the dopamine agonist quinagolide

1 reference

12 December 2020

Prolactin and autoimmunity

1 reference

12 December 2020

Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis

1 reference

12 December 2020

Bromocriptine and cyclosporin A combination therapy in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22737416%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

22737416

1 reference